ArrowArtboardCreated with Sketch.Title ChevronTitle ChevronIcon FacebookIcon LinkedinIcon Mail ContactPath LayerIcon MailPositive ArrowIcon PrintIcon Twitter
COVID vaccines

Sinovac booster insufficient against omicron, study shows

China COVID vaccine fails to produce enough antibodies: Hong Kong universities

A healthcare worker and Sinovac vaccine recipient in Jakarta, Indonesia, on Dec. 14. Sinovac says that 94% of those who receive three doses of its vaccine generate enough neutralizing antibodies to protect against the omicron variant.   © Reuters

HONG KONG -- A third dose of Sinovac's COVID vaccine does not provide sufficient protection against the omicron variant, new research reveals, contradicting the Chinese vaccine maker's pronouncement that it does.

Sponsored Content

About Sponsored Content This content was commissioned by Nikkei's Global Business Bureau.

Nikkei Asian Review, now known as Nikkei Asia, will be the voice of the Asian Century.

Celebrate our next chapter
Free access for everyone - Sep. 30

Find out more